FTO in health and disease
Open Access
- 18 December 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 12, 1500394
Abstract
Fat mass and obesity-associated (FTO) protein, a key enzyme integral to the dynamic regulation of epitranscriptomic modifications in RNAs, significantly influences crucial RNA lifecycle processes, including splicing, export, decay, and translation. The role of FTO in altering the epitranscriptome manifests across a spectrum of physiological and pathological conditions. This review aims to consolidate current understanding regarding the implications of FTO in health and disease, with a special emphasis on its involvement in obesity and non-communicable diseases associated with obesity, such as diabetes, cardiovascular disease, and cancer. It also summarizes the established molecules with FTO-inhibiting activity. Given the extensive impact of FTO on both physiology and pathophysiology, this overview provides illustrative insights into its roles, rather than an exhaustive account. A proper understanding of FTO function in human diseases could lead to new treatment approaches, potentially unlocking novel avenues for addressing both metabolic disorders and malignancies. The evolving insights into FTO’s regulatory mechanisms hold great promise for future advancements in disease treatment and prevention.Keywords
Funding Information
- Grantová Agentura České Republiky (24-10497S)
- Ministerstvo Školství, Mládeže a Tělovýchovy (grant Inter-COST LUC24089 LX22NPO5104)
This publication has 187 references indexed in Scilit:
- FTO up‐regulation induced by MYC suppresses tumour progression in Epstein‒Barr virus‐associated gastric cancerClinical and Translational Medicine, 2023
- FTO is a major genetic link between breast cancer, obesity, and diabetesBreast Cancer Research and Treatment, 2023
- Sex and Race Differences in Obesity-Related Genetic Susceptibility and Risk of Cardiometabolic Disease in Older US AdultsJAMA Network Open, 2023
- FTO‐mediated m6A modification of SOCS1 mRNA promotes the progression of diabetic kidney diseaseClinical and Translational Medicine, 2022
- Changes in m6A RNA Methylation Contribute to Heart Failure Progression by Modulating TranslationEuropean Journal of Heart Failure, 2019
- FTO, m6Am, and the hypothesis of reversible epitranscriptomic mRNA modificationsFEBS Letters, 2018
- FTO regulates the chemo‐radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β‐catenin through mRNA demethylationMolecular Carcinogenesis, 2018
- FTO genetic variants and risk of obesity and type 2 diabetes: A meta‐analysis of 28,394 IndiansObesity, 2013
- FTO gene variants are strongly associated with type 2 diabetes in South Asian IndiansDiabetologia, 2008
- Cloning of Fatso ( Fto ), a novel gene deleted by the Fused toes ( Ft ) mouse mutationMammalian Genome, 1999